Upgrade to SI Premium - Free Trial

Arbutus Biopharma (ABUS)

4.38 -0.09 (2.01%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/30/26)

Latest Headlines

Form 8-K Arbutus Biopharma Corp For: Jul 15 July 16, 2026 7:31 AM - SEC Filing Arbutus sues Pfizer and BioNTech over LNP patents in 3 countries July 16, 2026 7:30 AM - StreetInsider Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech, Receives First Payment From Moderna Settlement Agreement and Announces Intent to Return Capital to July 16, 2026 7:30 AM - StreetInsider Form 4 Arbutus Biopharma Corp For: Jun 08 Filed by: Sawhney Roger June 10, 2026 4:06 PM - SEC Filing Form 4 Arbutus Biopharma Corp For: Jun 08 Filed by: Beardsley Robert A June 10, 2026 4:05 PM - SEC Filing Form S-8 Arbutus Biopharma Corp June 5, 2026 4:06 PM - SEC Filing Form 8-K Arbutus Biopharma Corp For: May 26 May 27, 2026 4:02 PM - SEC Filing Form SCHEDULE 13G/A Arbutus Biopharma Corp Filed by: Two Seas Capital LP May 15, 2026 5:34 PM - SEC Filing Arbutus Biopharma (ABUS) Tops Q1 EPS by 91c May 13, 2026 7:47 AM - StreetInsider Form 10-Q Arbutus Biopharma Corp For: Mar 31 May 13, 2026 7:32 AM - SEC Filing Form 8-K Arbutus Biopharma Corp For: May 13 May 13, 2026 7:31 AM - SEC Filing Arbutus Reports First Quarter 2026 Financial Results and Provides Corporate Update May 13, 2026 7:30 AM - Globe NewsWire Form SCHEDULE 13D/A Arbutus Biopharma Corp Filed by: Whitefort Capital Management, LP April 28, 2026 5:55 PM - SEC Filing Full Article List